#enzymes market research

[me-amaraja]

Agricultural Enzymes Market Applications in Organic and Conventional Farming

Agricultural Enzymes Market Growth Strategic Market Overview and Growth Projections

The global agricultural enzymes market size was valued at USD 316.66 million in 2022. It is estimated to reach USD 548.77 million by 2031, growing at a CAGR of 6.3% during the forecast period (2023–2031).

The latest Global Agricultural Enzymes Market by straits research provides an in-depth analysis of the Agricultural Enzymes Market, including its future growth potential and key factors influencing its trajectory. This comprehensive report explores crucial elements driving market expansion, current challenges, competitive landscapes, and emerging opportunities. It delves into significant trends, competitive strategies, and the role of key industry players shaping the global Agricultural Enzymes Market. Additionally, it provides insight into the regulatory environment, market dynamics, and regional performance, offering a holistic view of the global market’s landscape through 2032.

Competitive Landscape

Some of the prominent key players operating in the Agricultural Enzymes Market are 

Bayer CropScience

BASF SE

Stoller USA Inc.

Corteva Agriscience

Elemental Enzymes

American Vanguard Corporation

Bioworks Inc.

Syngenta AG.

Get Free Request Sample Report @ https://straitsresearch.com/report/agricultural-enzymes-market/request-sample

The Agricultural Enzymes Market Research report delivers comprehensive annual revenue forecasts alongside detailed analysis of sales growth within the market. These projections, developed by seasoned analysts, are grounded in a deep exploration of the latest industry trends. The forecasts offer valuable insights for investors, highlighting key growth opportunities and industry potential. Additionally, the report provides a concise dashboard overview of leading organizations, showcasing their effective marketing strategies, market share, and the most recent advancements in both historical and current market landscapes.Global Agricultural Enzymes Market: Segmentation

The Agricultural Enzymes Market segmentation divides the market into multiple sub-segments based on product type, application, and geographical region. This segmentation approach enables more precise regional and country-level forecasts, providing deeper insights into market dynamics and potential growth opportunities within each segment.

By Type

Phosphatases

Dehydrogenases

Ureases

Proteases

Other Enzyme Types

By Applications

Crop Protection

Fertility

Plant Growth Regulation

By Crop Type

Grains and Cereals

Oil Seeds and Pulses

Fruits and Vegetables

Other Crop Types

Stay ahead of the competition with our in-depth analysis of the market trends!

Buy Now @ https://straitsresearch.com/buy-now/agricultural-enzymes-market

Market Highlights:

A company's revenue and the applications market are used by market analysts, data analysts, and others in connected industries to assess product values and regional markets.

But not limited to: reports from corporations, international Organization, and governments; market surveys; relevant industry news.

Examining historical market patterns, making predictions for the year 2022, as well as looking forward to 2032, using CAGRs (compound annual growth rates)

Historical and anticipated data on demand, application, pricing, and market share by country are all included in the study, which focuses on major markets such the United States, Europe, and China.

Apart from that, it sheds light on the primary market forces at work as well as the obstacles, opportunities, and threats that suppliers face. In addition, the worldwide market's leading players are profiled, together with their respective market shares.

Goals of the Study

What is the overall size and scope of the Agricultural Enzymes Market market?

What are the key trends currently influencing the market landscape?

Who are the primary competitors operating within the Agricultural Enzymes Market market?

What are the potential growth opportunities for companies in this market?

What are the major challenges or obstacles the market is currently facing?

What demographic segments are primarily targeted in the Agricultural Enzymes Market market?

What are the prevailing consumer preferences and behaviors within this market?

What are the key market segments, and how do they contribute to the overall market share?

What are the future growth projections for the Agricultural Enzymes Market market over the next several years?

How do regulatory and legal frameworks influence the market?

About Straits Research

Straits Research is dedicated to providing businesses with the highest quality market research services. With a team of experienced researchers and analysts, we strive to deliver insightful and actionable data that helps our clients make informed decisions about their industry and market. Our customized approach allows us to tailor our research to each client's specific needs and goals, ensuring that they receive the most relevant and valuable insights.

Contact Us

Email: sales@straitsresearch.com 

Tel: UK: +44 203 695 0070, USA: +1 646 905 0080

[aishavass]

Rising demand for clean energy is expected to propel the White Biotechnology Enzymes market growth. On the basis of region, North America is expected to be...

[research320]

Industrial Enzymes Market to Capture a CAGR of 6.27% Between 2023 and 2030 While Touching Approximately USD 10.80 Billion by 2030-End – Report by Market Research Future (MRFR)

[medicaldevicesindustrynews]

Which Industries are Making the Best Use of Industrial Enzymes?

Enzymes increase the speed of reactions and improves the yield by increasing accessible precursors for downstream reactions. The most obvious use for enzymes in business is the process of production of bread, cheese and alcohol. In these applications the enzymes are a part of microorganism machinery, such as yeast or bacterium. Purity of Enzymes is Essential Enzymes are used for producing…

[mrudula01]

Medical Enzymes Market: Global Demand soars R&D Investment

Healthcare

03, August 2022

In recent years, the prevalence of metabolism-related diseases and global health scenarios have compelled people to shift towards healthier lifestyles. Also, after COVID-19, consumers have become conscious about their health, leading to increased use of enzymes-based nutritional and immunity-boosting products.

Our studies indicate that the global medical enzymes market will advance at a CAGR of 6.78% during the forecast period 2022-2028. Factors accelerating this growth include advancement in enzyme engineering, increased demand in the pharmaceutical sector and the prevalence of gastrointestinal disorders, cancers and tumors.

As per the prediction of the American Cancer Society Journal, there will be approximately 1.9 million new cancer diagnoses and 6 lakh cancer-related deaths in the United States. To prevent the spread of cancer cells, enzymes are employed as therapeutic agents to strengthen the immune system and eliminate undesired cells. Cancers like leukemia have been treated with enzymes such as lkaline phosphatase, beta-glucosidases, etc., creating lucrative prospects for the global market.

On the other hand, strict regulatory processes and safety procedures while handling medical enzymes have challenged market players. Safety concerns for handling enzymes arise due to the toxic by-products emitted in the preparation process. To ensure that the products do not contain toxins, medicinal products are subject to regulations like Directive 65/65/EEC. Further, enzyme exposure is associated with risks like respiratory allergies and irritation in skin and eyes that must be controlled using proper mechanisms like isolation and contamination.

Expanding Applications Drives Market Growth

Properties of medical enzymes like breaking internal blood clots, dissolving wound swelling and promoting healing are expanding their application in treating various diseases such as gastrointestinal disorders, cardiovascular diseases and coagulation disorders, and cancer therapy. Enzyme biosensors like alkaline phosphatase, creatine kinase, aminotrans-ferases, dehydrogenases and others are used as analytical tools in diagnosing diseases.

Thrombolytic enzymes have great potential owing to their great affinity, specificity, catalytic activity, and stability. It is the leading segment in the type category. These enzymes find application in the treatment and diagnosis of blood clots at an early stage by activating plasminogen and developing a cleaved product called plasmin.

Industry Component and Scope

The components that frame the market and help in its growth are research & development, operations, and outbound logistics. To improve productivity and efficiency, operations analysis is crucial for confirming the quality and safety standards of the items delivered to the consumers.

With digitalization and advancement in engineering techniques, research is increasing to develop new products with quality standards. The advancement in research includes applied enzymology, enzyme therapy, novel application of enzymes, etc. The main aim of advanced techniques is the development of competitive and financially feasible products.

Outbound logistics includes optimization of product delivery costs and timely management with customer satisfaction to increase market growth opportunities.

Geographical Standpoint

Asia-Pacific will likely rise at a CAGR of 7.67% in the forecasting years. Rapid industrialization, rise in R&D expenditure, technological advancements and production techniques are the major factors driving the regional market.

For instance, immobilized enzyme technology enhances the properties of food enzymes and protein engineering. Additionally, it is anticipated that the growing attention of major pharmaceutical corporations to outsourcing drug discovery to all of Asia will help the market expand.

Furthermore, North America holds the leading position while rising at a CAGR of 6.57% and is expected to gain momentum over the forecasting years. The growth is due to the development of advanced products by the region’s companies. The mergers and acquisitions among the established players like Novus, DuPont and Thermo Fisher Scientific fuel the studied market.

For instance, the acquisition of Precision Biotics by Novozymes for $88.5 million gives latter a stronger entry point into the human probiotics supplement market.

Conclusive Statement

The upsurge in the medical enzymes market is due to the rising health issues, growing customer awareness and utilization of healthcare specialty enzymes in several diagnostic and research activities. Drugs going off-patent will provide growth opportunities for the companies to develop new medical enzymes and focus on R&D.

The goal of advanced research in this field is to develop products that are not only competitive but economically viable. This has led to many mergers and acquisitions between dominant companies to upsurge enzymes' production, research and development. For instance, Sanofi shelled out $3.68 billion to buy Principia, which will advance the company’s R&D and accelerate the development of medicines.

FAQ

Question: What is market growth in terms of revenue? Answer: The global medical enzymes market was valued at $4355.27 million in 2021 and is expected to reach $6878.46 million by 2028. Question: Which enzyme type is expected to raise market growth? Answer: Hydrolase Enzyme captured the largest market share of over 35.887% in 2021. It is biochemical catalysts that use water to break down a chemical bond, dividing a larger molecule into smaller ones.

[maryharrisk5]

The global white biotechnology enzymes market is anticipated to be valued at USD 12,047.1 million in 2025

[evonnebaker]

Rising demand for clean energy is expected to propel the White Biotechnology Enzymes market growth. On the basis of region, North America is expected to be the largest market due to the rising growth of industries such as biofuel, cleaning products, and food & beverages

[dailyanarchistposts]

Author: Kevin Carson Topic: health care

Alternet has an interview with Dr. Richard Deyo, who co-authored Hope or Hype: The Obsession with Medical Advances and the High Cost of False Promises. Some excellent bits of analysis, although (like a typical goo-goo) he gets the big picture wrong.

The problem with me-too drugs is a big one. Me-too drugs are chemically very similar to other drugs already available, yet they are typically marketed as if they were important new breakthroughs, and typically with very high prices. We found in many cases that new, expensive me-too drugs are not necessarily better than older generic and less expensive drugs. Because new and heavily marketed drugs seem like they must be better, manufacturers can command higher prices. That is an important driver of drug costs.

The central factor in this process is the state’s patent policies, which drastically inflate the profitability of the newer “me, too” drugs against much cheaper competitors that do very nearly the same thing. Indeed, the patent process has a huge distorting effect on R&D, since it results in so many resources being channelled into tweaking existing drugs just enough so that they can be re-patented as “new.” Then the drug reps hit every hospital and clinic in America, drop off some free samples and pamphlets, and (most M.D.s relying on drug industry handouts for their information on the new drugs that have come out since they left med school) the “me, too” drug becomes the new standard form of treatment.

The state having created the “honey pot” with its patent system, it is quite predictable that the state-enforced drug cartels and the white-coat Mafia (medical licensing boards with their mainly pharma-influenced “standards of practice”) should drive the industry toward a model focused on these high-cost drugs, and crowd out low-cost alternatives.

Any doc who (say) recommends Co-Enzyme Q-10 as a first recourse against congestive heart failure, or attempts some other low-cost departure from the drug-‘em-and-cut-‘em model, had better remember the state licensing board has its eye on him. Even stipulating that patents themselves are legitimate (which they are not), this latter practice has the effect of outlawing one of the most important defenses against monopoly: what Schumpeter called “product-substitution.”

The fact that the authors’ proposed response to this state capitalist sewer is even more state intervention (finessing the FDA approval process, more regulation of advertising, more procedural oversight of research), rather than eliminating the forms of state intervention that create the honey-pot in the first place, is mind-boggling. It’s like looking at one of those Rube Goldberg inventions.

Speaking of inventions.... One of the best regular features on MST3K was the weekly “Inventions” segment. My favorite was a treadmill with motorized wheels on the bottom, just in case you felt like moving around outside while you were walking. But with big government liberals making proposals like these, it’s hard for the farceurs on the Satellite of Love to compete.

[psychicsheeparcade]

Lactose Intolerance Market Growth, Opportunities and Industry Forecast Report 2034

Lactose intolerance is a digestive disorder where individuals cannot digest lactose, a sugar found in milk and dairy products. This has led to a significant demand for lactose-free products, including dairy alternatives and enzyme supplements, creating a thriving market. The lactose intolerance market is expected to see strong growth in the coming years, driven by rising lactose intolerance cases, particularly in Asia-Pacific, where a large percentage of the population is affected.

The  lactose intolerance Market related products, including lactose-free foods, beverages, and lactase supplements, has witnessed strong growth. The global lactose-free market was valued at around USD 12 billion in 2022 and is projected to reach USD 18-20 billion by 2030, growing at a compound annual growth rate (CAGR) of approximately 6-7%. The rising consumer awareness about the digestive issues associated with lactose intolerance is a key factor driving this growth.

Get a Sample Copy of Report, Click Here: https://wemarketresearch.com/reports/request-free-sample-pdf/global-lactose-intolerance-market/1521

Lactose Intolerance Market Drivers

Several factors are driving the growth of the lactose intolerance market:

Increasing Prevalence: Studies indicate that over 65% of the global population has some degree of lactose intolerance, leading to higher demand for solutions.

Rising Health Awareness: As more consumers seek to avoid gastrointestinal discomfort associated with lactose consumption, awareness campaigns and medical advice have led to a surge in demand for lactose-free products.

Dairy Alternatives: Growing interest in plant-based diets is pushing demand for lactose-free dairy alternatives like almond, soy, oat, and coconut milk. Veganism is another contributing factor here.

Product Innovations: Manufacturers are developing lactose-free dairy products, including milk, cheese, and yogurt, as well as supplements like lactase enzymes.

Lactose Intolerance Market Trends

Consumer Preference Shift: There has been a notable shift toward plant-based alternatives and lactose-free products as consumers seek more sustainable and healthy choices.

Fortification of Dairy Alternatives: Companies are fortifying plant-based products with nutrients like calcium, vitamin D, and protein to match the nutritional profile of traditional dairy.

Online Retail Growth: The rise of e-commerce platforms has made lactose-free products more accessible, increasing consumer convenience and fueling market growth.

Lactose Intolerance Market Challenges

Product Cost: Lactose-free products are often more expensive than their traditional counterparts, which can limit their appeal to cost-sensitive consumers.

Taste and Texture: Some consumers may still prefer the taste and texture of regular dairy products, which can make transitioning to lactose-free or plant-based alternatives challenging.

Lactose Intolerance Market Regional Analysis

North America and Europe are leading markets for lactose-free products, driven by well-established dairy industries and rising lactose intolerance awareness. The U.S. and Germany are key markets in these regions.

The Asia-Pacific region is expected to witness the highest growth, fueled by the high prevalence of lactose intolerance, particularly in countries like China, India, and Japan. The region’s large population, combined with increased disposable income and growing awareness of lactose intolerance, is propelling the market forward.

Lactose Intolerance Market Segmentation,

Product Type:

Lactose-Free Dairy Products: Milk, cheese, yogurt, ice cream.

Dairy Alternatives: Soy milk, almond milk, rice milk, oat milk.

Distribution Channel:

Supermarkets and Hypermarkets

Online Stores

Specialty Stores

Convenience Stores

Key companies profiled in this research study are,

Nestlé S.A.

Danone S.A.

The Coca-Cola Company (Fairlife)

Johnson & Johnson (Lactaid)

General Mills, Inc.

Valio Ltd.

Arla Foods amba

Dean Foods Company

Parmalat S.p.A.

Saputo Inc.

Conclusion

The Lactose Intolerance Market is poised for sustained growth, driven by increasing global awareness of lactose intolerance and the rising demand for lactose-free and dairy alternative products. As more individuals seek health-conscious, digestive-friendly, and sustainable options, the market for lactose-free dairy, plant-based alternatives, and lactase supplements will continue to expand. However, challenges such as product cost and taste preferences need to be addressed through innovation. With major industry players focusing on product development and fortification, the future of the lactose intolerance market appears promising, offering both consumers and businesses a wide range of opportunities.

[posallys]

h\Hey Taylor! I always see you post about university and such, and I was just wondering what all you do? I know you're studying biology, but you talk about some other things too. I was also wondering if you had any tips? I'm also studying biology but I'm a few years behind you. All the best!

Okay so this semester I'm taking orgo, ecology, advanced micro (which is just 6 hours of lab and no lecture), and cognitive neuroscience, as well as doing independent research with the worms I was working with over the summer <3 I'm also the TA for one of the intro biology classes at my school, and I'm a tutor, so I tutor all of the intro bio, intro chem, calc 1 and a little 2, pretty much all of the psych classes I've taken, stats, and a few of the lit classes I've taken. That's about 9 hours a week, and it's a service through the uni so they just book an appointment and tell me which class they need :) I'm also the main tutor for both of our intro bio classes (intro molecular and organismal), so I do a twice-weekly remedial "lecture" for an hour. i am. so fucking busy lol OH AND ALSO the chair of the psych dept just asked me to be on their hiring committee because they're trying to get a neuropsych person in, and he was talking to my research supervisor abt how she stole me from the psych dept, and wanted my input on the new hire so they don't keep loosing every single person with an interest in neuro to the bio dept since my school doesn't have a real neuro major.

as for tips...vocab is your best friend. even if you don't know what's going on, look at the prefixes, suffixes, etc because they'll tell you!!! learn them!! for example, anything with -ase at the end is most likely an enzyme....and enzymes are proteins that help catalyze biochemical reactions. so if you see the word "lactase" and you had no clue what that was, you know off the bat it's probably an enzyme (-ase), and if you can see that 'lact' is the root of lactose....well, you can logic your way to the fact that lactase helps you break down lactose! know your vocab I literally cannot stress it enough. also ESPECIALLY for chem when you get passed gen chem. the words are there to tell you what the thing is....they're not random. they actually mean something.

literally go to lecture. even when you don't want to. get up and go. and don't be on your phone. don't try to take notes on your laptop, either. do it, bare minimum, with an iPad, but if you still get distracted by notifications then use a notebook. who cares if you're the only one...you'll also be the only one who can draw diagrams, models, chemical structures, etc. plus writing literally activates parts of your brain involved with memory retention while typing does not. don't use the laptop!!!

oh i also mean this in the nicest way possible, but don't do bio if you're not super into it. because you'll hate it and all of the effort you have to put in is going to make it feel like hell. and if you find yourself hating labs....i hate to break it to you but you probably shouldn't do bio because most of the jobs on the market involve bench work in some way, shape, or form, and if you can't sit through a 3 or 4 hour teaching lab you're probably going to want to die when you have to get a real job after you graduate. in my schedule right now I have 16 hours of lab a week, and I love every single minute of it.

ask for help! i can say this as a TA but genuinely everyone wants to see you do well. go bug your TAs and your profs and yeah you might feel like you're being annoying but who cares! you learn by asking questions so if you have them, ask them. i think all of my profs are so fucking sick of seeing my face, and yet I'm still in the dept way too often bugging them while they're in between classes and meetings lol

along the same lines...literally everything is about connections. go talk to your profs. even if it's not with questions. "oh, hey, I thought this part of the lecture was cool, could you maybe tell me some more about it?" things like that. after all if you want to go to grad school of whatever kind, they're the ones that are ultimately going to help you get their. they're how you get research opportunities, rec letters, maybe they even pull some strings to get you in classes that are full/you don't have prereqs for, etc if they like you enough! some of my profs ask me for input on their classes too. like my micro prof, who's my academic advisor. i had him for regular micro last semester, and I saw him while doing research over the summer and he had 3 or 4 ideas for our advanced micro lab class this semester. he asked me what I liked best....guess which project we're doing.

learn how to read papers. it's hard. you're gonna want to scream and cry and rip your hair out. you're not going to understand 90%+ of what they're saying when you start. highlight words you don't know and look them up. ask profs (yes. again. talk their ears off when they have time to listen to you) for tips because it really depends on the field, what you want to get out of the paper (i.e. are you looking for methodology to model, are you doing a follow up to their conclusions, do you need their results as background). I'm reading three papers right now and I understand nothing! it sucks it's hard as an undergrad. I want to yell but. I'm taking notes and trying to break the info down into smaller pieces and. i think it's working :)

okay i'm just rambling but!! hope this helps :)

[marta-bee]

Good Omens time! (Isn’t it always?) Today I read the start of the “Friday” section, when Famine gets his object of the Apocalypse, his brass scale to match War’s flaming sword. It’s a cute scene anyone who’s worked in fast-food or a customer-facing job like retail will probably appreciate. Or for that matter anyone who’s actually stepped foot in a McDonald’s; which is, you know, all of us.

Sable sauntered in to the Burger Lord. It was exactly like every other Burger Lord in America. [But not like every other Burger Lord across the world. German Burger Lords, for example, sold lager instead of root beer, while English Burger Lords managed to take any American fast food virtues (the speed with which your food was delivered, for example) and carefully remove them; your food arrived after half an hour, at room temperature, and it was only because of the strip of warm lettuce between them that you could distinguish the burger from the bun. The Burger Lord pathfinder salesmen had been shot twenty-five minutes after setting foot in France.] McLordy the Clown danced in the Kiddie Korner. The serving staff had identical gleaming smiles that never reached their eyes. And behind the counter a chubby, middle-aged man in a Burger Lord uniform, slapped burgers onto the griddle, whistling softly, happy in his work.

Sable went up to the counter.

"Hello-my-name-is-Marie," said the girl behind the counter. "How-can-i-help-you?" "A double blaster thunder biggun, extra fries, hold the mustard," he said.

"Anything-to-drink?"

"A special thick whippy chocobanana shake."

She pressed the little pictogram squares on her till. (Literacy was no longer a requirement for employment in these restaurants. Smiling was.) Then she turned to the chubby man behind the counter.

"DBTB, E F, hold mustard," she said. "Choco-shake."

"Uhhnhuhn," crooned the cook. He sorted the food into little paper containers, pausing only to brush the graying cowlick from his eyes.

"Here y'are," he said.

She took them without looking at him, and he returned cheerfully to his griddle, singing quietly. "Loooove me tender, loooove me long, neeeever let me go...."

The man's humming, Sable noted, clashed with the Burger Lord background music, a tinny tape loop of the Burger Lord commercial jingle, and he made a mental note to have him fired.

It’s so predictable; so dehumanizing. Intelligence and even basic education to the point of literacy isn’t needed; bland mechanization and the ability to not stand out is.

Famine actually owns the joint, not to make money (though the end result is pretty much indistinguishable from chains with that goal) but to get people who aren’t diet-crazed and faddish enough to willingly give up nutrition to to be thin. This is his unique brand of starvation brought to the masses.

The Newtrition corporation had started small, eleven years ago. A small team of food scientists, a huge team of marketing and public relations personnel, and a neat logo.

Two years of Newtrition investment and research had produced CHOW. CHOW contained spun, plaited, and woven protein molecules, capped and coded, carefully designed to be ignored by even the most ravenous digestive tract enzymes; no-cal sweeteners; mineral oils replacing vegetable oils; fibrous materials, colorings, and flavorings. The end result was a foodstuff almost indistinguishable from any other except for two things. Firstly, the price, which was slightly higher, and secondly the nutritional content, which was roughly equivalent to that of a Sony Walkman. It didn't matter how much you ate, you lost weight. [And Hair. And skin tone. And, if you ate enough of it long enough, vital signs.]

Fat people had bought it. Thin people who didn't want to get fat had bought it. Chow was the ultimate diet food-carefully spun, woven, textured, and pounded to imitate anything, from potatoes to venison, although the chicken sold best.

Sable sat back and watched the money roll in. He watched CHOW gradually fill the ecological niche that used to be filled by the old, untrademarked food.

He followed Chows with Snacks junk food made from real junk. MEALS was Sable's latest brainwave.

MEALS was CHOW) with added sugar and fat. The theory was that if you ate enough MEALS you would a) get very fat, and b) die of malnutrition.

The paradox delighted Sable.

There’s something very gently sad about all of this, really. People buying this mass-produced slop and not realizing what they’re putting in their body is quite literally useless. It’s non-food; anti-food, even. I don’t blame the people making that “choice,” they’re certainly no more or less deceived than the folks stopping into a KFC down the road. It’s just very ad that this is what the system drives us to. Now even more than twenty-odd years ago.

This started out as a cute scene about the banality of being trapped under the thumb of capitalism. It is that to be sure, but a little too near the truth to be laughed off, at least for me. Famine isn’t a starving child in Africa with his ribs protruding out from his skin, or at least it’s not just them. It’s the workaday person being ground down into just a cog in the machine, and whose real value is an ability not to stand out.

That’s tragic in its way, and all too true to life. It’s not just a truth for low-wage workers; I’m a definite white-collar middle-class knowledge-worker and thinking about how much of my own employability relies on something rather similar, though the privileges and benefits I get through my own ability to work in the system do make for a much more comfortable life.

I think I need to stop here and sit with this a bit. Definitely whichever one of Neil or Terry wrote this particular scene, they knocked it out of the park. There’s more with the Them coming up I see, and I wouldn’t be surprised if Aziraphale and Crowley were waiting in the offing a well, but they can wait until next weekend.